 | • レポートコード：QYR9N7493 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、黄斑変性症の薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・黄斑変性症の薬の世界市場規模 ・主要企業別市場シェア ・黄斑変性症の薬の世界市場規模：種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他） ・黄斑変性症の薬の世界市場規模：用途別（50〜60歳、60〜70歳、その他） ・黄斑変性症の薬のアメリカ市場規模（種類別、用途別） ・黄斑変性症の薬のヨーロッパ市場規模（種類別、用途別） ・黄斑変性症の薬の中国市場規模（種類別、用途別） ・黄斑変性症の薬の日本市場規模（種類別、用途別） ・黄斑変性症の薬の東南アジア市場規模（種類別、用途別） ・黄斑変性症の薬のインド市場規模（種類別、用途別） ・黄斑変性症の薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・黄斑変性症の薬の世界市場予測（2019年-2025年） ・黄斑変性症の薬の地域別市場予測（2019年-2025年） ... |
Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above.The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising markets in the upcoming period.
In 2018, the global Macular Degeneration Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Macular Degeneration Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Degeneration Drugs development in United States, Europe and China.
The key players covered in this study
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
…
Market segment by Type, the product can be split into
Lucentis
Eylea
Avastin
Squalamine
Conercept
Lampalizamab
Other
Market segment by Application, split into
50-60 Years Old
60-70 Years Old
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Macular Degeneration Drugs status, future forecast, growth opportunity, key market and key players.
To present the Macular Degeneration Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Macular Degeneration Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Macular Degeneration Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Lucentis
1.4.3 Eylea
1.4.4 Avastin
1.4.5 Squalamine
1.4.6 Conercept
1.4.7 Lampalizamab
1.4.8 Other
1.5 Market by Application
1.5.1 Global Macular Degeneration Drugs Market Share by Application (2014-2025)
1.5.2 50-60 Years Old
1.5.3 60-70 Years Old
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Macular Degeneration Drugs Market Size
2.2 Macular Degeneration Drugs Growth Trends by Regions
2.2.1 Macular Degeneration Drugs Market Size by Regions (2014-2025)
2.2.2 Macular Degeneration Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Macular Degeneration Drugs Market Size by Manufacturers
3.1.1 Global Macular Degeneration Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Macular Degeneration Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Macular Degeneration Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Macular Degeneration Drugs Key Players Head office and Area Served
3.3 Key Players Macular Degeneration Drugs Product/Solution/Service
3.4 Date of Enter into Macular Degeneration Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Macular Degeneration Drugs Market Size by Type (2014-2019)
4.2 Global Macular Degeneration Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Macular Degeneration Drugs Market Size (2014-2019)
5.2 Macular Degeneration Drugs Key Players in United States
5.3 United States Macular Degeneration Drugs Market Size by Type
5.4 United States Macular Degeneration Drugs Market Size by Application
6 Europe
6.1 Europe Macular Degeneration Drugs Market Size (2014-2019)
6.2 Macular Degeneration Drugs Key Players in Europe
6.3 Europe Macular Degeneration Drugs Market Size by Type
6.4 Europe Macular Degeneration Drugs Market Size by Application
7 China
7.1 China Macular Degeneration Drugs Market Size (2014-2019)
7.2 Macular Degeneration Drugs Key Players in China
7.3 China Macular Degeneration Drugs Market Size by Type
7.4 China Macular Degeneration Drugs Market Size by Application
8 Japan
8.1 Japan Macular Degeneration Drugs Market Size (2014-2019)
8.2 Macular Degeneration Drugs Key Players in Japan
8.3 Japan Macular Degeneration Drugs Market Size by Type
8.4 Japan Macular Degeneration Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Macular Degeneration Drugs Market Size (2014-2019)
9.2 Macular Degeneration Drugs Key Players in Southeast Asia
9.3 Southeast Asia Macular Degeneration Drugs Market Size by Type
9.4 Southeast Asia Macular Degeneration Drugs Market Size by Application
10 India
10.1 India Macular Degeneration Drugs Market Size (2014-2019)
10.2 Macular Degeneration Drugs Key Players in India
10.3 India Macular Degeneration Drugs Market Size by Type
10.4 India Macular Degeneration Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Macular Degeneration Drugs Market Size (2014-2019)
11.2 Macular Degeneration Drugs Key Players in Central & South America
11.3 Central & South America Macular Degeneration Drugs Market Size by Type
11.4 Central & South America Macular Degeneration Drugs Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Macular Degeneration Drugs Introduction
12.1.4 Novartis Revenue in Macular Degeneration Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Bayer Healthcare
12.2.1 Bayer Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Macular Degeneration Drugs Introduction
12.2.4 Bayer Healthcare Revenue in Macular Degeneration Drugs Business (2014-2019)
12.2.5 Bayer Healthcare Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Macular Degeneration Drugs Introduction
12.3.4 Roche Revenue in Macular Degeneration Drugs Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Neurotech Pharmaceuticals
12.4.1 Neurotech Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Macular Degeneration Drugs Introduction
12.4.4 Neurotech Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2014-2019)
12.4.5 Neurotech Pharmaceuticals Recent Development
12.5 Regeneron Pharmaceuticals
12.5.1 Regeneron Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Macular Degeneration Drugs Introduction
12.5.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2014-2019)
12.5.5 Regeneron Pharmaceuticals Recent Development
12.6 Allergan
12.6.1 Allergan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Macular Degeneration Drugs Introduction
12.6.4 Allergan Revenue in Macular Degeneration Drugs Business (2014-2019)
12.6.5 Allergan Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Macular Degeneration Drugs Key Market Segments
Table Key Players Macular Degeneration Drugs Covered
Table Global Macular Degeneration Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Macular Degeneration Drugs Market Size Market Share by Type 2014-2025
Figure Lucentis Figures
Table Key Players of Lucentis
Figure Eylea Figures
Table Key Players of Eylea
Figure Avastin Figures
Table Key Players of Avastin
Figure Squalamine Figures
Table Key Players of Squalamine
Figure Conercept Figures
Table Key Players of Conercept
Figure Lampalizamab Figures
Table Key Players of Lampalizamab
Figure Other Figures
Table Key Players of Other
Table Global Macular Degeneration Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure 50-60 Years Old Case Studies
Figure 60-70 Years Old Case Studies
Figure Other Case Studies
Figure Macular Degeneration Drugs Report Years Considered
Table Global Macular Degeneration Drugs Market Size 2014-2025 (Million US$)
Figure Global Macular Degeneration Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Macular Degeneration Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Macular Degeneration Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Macular Degeneration Drugs Market Share by Regions 2014-2019
Figure Global Macular Degeneration Drugs Market Share by Regions 2014-2019
Figure Global Macular Degeneration Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Macular Degeneration Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Macular Degeneration Drugs Market Share by Manufacturers (2014-2019)
Figure Global Macular Degeneration Drugs Market Share by Manufacturers in 2018
Table Global Macular Degeneration Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Macular Degeneration Drugs Product/Solution/Service
Table Date of Enter into Macular Degeneration Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Macular Degeneration Drugs Market Size Share by Type (2014-2019)
Figure Global Macular Degeneration Drugs Market Size Market Share by Type (2014-2019)
Table Global Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Macular Degeneration Drugs Market Size Share by Application (2014-2019)
Figure Global Macular Degeneration Drugs Market Size Market Share by Application (2014-2019)
Figure Global Macular Degeneration Drugs Revenue Market Share by Application in 2018
Figure United States Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table United States Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Macular Degeneration Drugs Market Share by Type (2014-2019)
Table United States Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Macular Degeneration Drugs Market Share by Application (2014-2019)
Figure Europe Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table Europe Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Macular Degeneration Drugs Market Share by Type (2014-2019)
Table Europe Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Macular Degeneration Drugs Market Share by Application (2014-2019)
Figure China Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table China Macular Degeneration Drugs Market Size by Type (2014-20189) (Million US$)
Table China Macular Degeneration Drugs Market Share by Type (2014-2019)
Table China Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table China Macular Degeneration Drugs Market Share by Application (2014-2019)
Figure Japan Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table Japan Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Macular Degeneration Drugs Market Share by Type (2014-2019)
Table Japan Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Macular Degeneration Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table Southeast Asia Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Macular Degeneration Drugs Market Share by Type (2014-2019)
Table Southeast Asia Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Macular Degeneration Drugs Market Share by Application (2014-2019)
Figure India Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table India Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table India Macular Degeneration Drugs Market Share by Type (2014-2019)
Table India Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table India Macular Degeneration Drugs Market Share by Application (2014-2019)
Figure Central & South America Macular Degeneration Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Macular Degeneration Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Macular Degeneration Drugs Market Share (2018-2019)
Table Central & South America Macular Degeneration Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Macular Degeneration Drugs Market Share by Type (2014-2019)
Table Central & South America Macular Degeneration Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Macular Degeneration Drugs Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Macular Degeneration Drugs Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Macular Degeneration Drugs Business (2014-2019)
Table Novartis Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Revenue in Macular Degeneration Drugs Business (2014-2019)(Million US$)
Figure Bayer Healthcare Revenue Growth Rate in Macular Degeneration Drugs Business (2014-2019)
Table Bayer Healthcare Recent Development
Table Roche Company Details
Table Roche Revenue in Macular Degeneration Drugs Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Macular Degeneration Drugs Business (2014-2019)
Table Roche Recent Development
Table Neurotech Pharmaceuticals Company Details
Table Neurotech Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2014-2019)(Million US$)
Figure Neurotech Pharmaceuticals Revenue Growth Rate in Macular Degeneration Drugs Business (2014-2019)
Table Neurotech Pharmaceuticals Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Drugs Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Allergan Company Details
Table Allergan Revenue in Macular Degeneration Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Macular Degeneration Drugs Business (2014-2019)
Table Allergan Recent Development
Table Global Macular Degeneration Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Macular Degeneration Drugs Market Size Share by Regions (2019-2025)
Figure Global Macular Degeneration Drugs Market Size Share by Regions in 2025
Figure United States Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Macular Degeneration Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Macular Degeneration Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Macular Degeneration Drugs Market Size by Product (2019-2025)
Figure Global Macular Degeneration Drugs Market Size by Product in 2025
Table Global Macular Degeneration Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Macular Degeneration Drugs Market Size by Application (2019-2025)
Figure Global Macular Degeneration Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の黄斑変性症の治療市場：市場規模・現状・予測 Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that m…- 世界の嚢胞状黄斑浮腫市場：市場規模・現状・予測 Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disrupti…
- 世界の糖尿病性黄斑浮腫の治療市場：市場規模・現状・予測 Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.Increasing prevalence of diabetes in the prime factor driving g…
- 世界の黄斑浮腫治療薬市場：市場規模・現状・予測 Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…
- 世界の網膜バイオシミラー市場：市場規模・現状・予測 In 2018, the global Retinal Biosimilars market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players. Th…